ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HEMO Hemogenyx Pharmaceuticals Plc

1.567
0.002 (0.13%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.002 0.13% 1.567 1.536 1.598 1.55 1.538 1.55 4,833,427 16:35:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.98M -0.0035 -4.40 17.59M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.57p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.125p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,141,999,321 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £17.59 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.40.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 551 to 573 of 13425 messages
Chat Pages: Latest  33  32  31  30  29  28  27  26  25  24  23  22  Older
DateSubjectAuthorDiscuss
06/3/2018
11:00
I’d say stig is spot on. 4.14 to sell. Not much interest except from people who bought and failed to sell on the spike.
sidjameslaugh
06/3/2018
10:59
Plummeting again. All the way back to 2p.
lodgeview
06/3/2018
10:16
Stig - sounding increasingly desperate.
tsmith2
06/3/2018
09:11
Hemo like sending RNS's and like above, I think more good news is due very soon indeed. It would not surprise me if we hear of " game changing" news in the next week or two. Dr Sheppard has been recruited for a reason and is associated with good Companies. He would not have joined unless it boots his reputation.
ernestsyngen
06/3/2018
08:36
yep, to me that is the true great news
the patient investor
06/3/2018
08:35
And he's sold on a string of embryo companies to majors, in the past.
andrbea
06/3/2018
08:34
also, the timing of his involvement must mean something is brewing and we may be close to further great news, you don't involve such a great figure just like that.

There is definitely something round the corner.
Often good RNSs lead to even better ones.

the patient investor
06/3/2018
08:32
Dr Shepard is a superb name for Hemo to have working for them. He knows this business very well indeed.
ernestsyngen
06/3/2018
08:31
thanks hattie1

I am a former scientist in a very different field (bacteria in plant pathology) and I often used to see great minds who sadly had limited business acumen and a disconnection with the industry.

This guy seems to have both a great brain and business intelligence in large amounts!


Meanwhile the MMs are playing their usual games scaring people as they certainly expect a huge demand for this share which, good for us, is very very illiquid.

I can easily see 10p in a few months.

the patient investor
06/3/2018
08:24
As a former Oncology nurse I'm very impressed at this appointment especially as Dr Shepard was involved with herceptin which has massive benefits for breast cancer patients ...
hattie1
06/3/2018
08:18
nor is 3p by the looks of it!
113mike
06/3/2018
08:12
this is much more remarkable than it seems.

this guy is not just a top scientist but somebody who helped creating multibillion selling new cutting edge drugs. He has already all the right contacts in the industry. To me this RNS is worth in itself 2-3p at least.

I am not saying it is as if a small IT company had acquired the combined services of Steve Jobs and Steve Wozniak but the comparison is not too far away.

this will make our tiny company super attractive to the big pharmas

10p is not far

the patient investor
06/3/2018
07:48
Great news. Onwards and upwards!
cudmore
06/3/2018
07:31
Commenting Dr. Shepard, said: "Hemogenyx is developing cancer therapies that have the potential to save lives, and I'm proud to be a part of that. As a member of Hemogenyx's Scientific Advisory Board, I'll be able to use the experience I've accrued working with other pre-clinical biotechnology programmes to help guide Hemogenyx toward the release of successful antibody-based therapies."
orchestralis
05/3/2018
22:52
Oh they are, they really are.
lufc5
05/3/2018
21:16
humanised mice alone must be worth a bomb
buddugoliaeth
05/3/2018
20:37
This will do a VAL. A long way off any realisation of value, will shortly be back at 3p.
rathean
05/3/2018
15:34
Tax you any way they can but a profit is still a profit!
ernestsyngen
05/3/2018
13:56
same here! i detest it
the patient investor
05/3/2018
13:39
Never knew you had to pay stamp duty buying this one but you do.

Hate doing that. So either I hold for a while or next I sell I will just not trade it again. One of my pet hates paying stamp duty on stocks now

dave4545
05/3/2018
13:37
cudmore
can you post link to broker note please

thx

or just post a brief summary

the patient investor
05/3/2018
13:28
I tired to buy on the drop but no chance whatsoever!!!!
billthebank
05/3/2018
13:24
Buyers getting on board now realising they are still way too cheap when you look at the realistic price these are worth
cudmore
Chat Pages: Latest  33  32  31  30  29  28  27  26  25  24  23  22  Older

Your Recent History

Delayed Upgrade Clock